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Supplementation with β-Hydroxy- β-Methylbutyrate 
(HMB) and α-Ketoisocaproic Acid (KIC)
Reduces Signs and Symptoms of Exercise-
Induced Muscle Damage in Man
Ken A. van Someren, Adam J. Edwards,
and Glyn Howatson
This study examined the effects of β-hydroxy- β-methylbutyrate (HMB) 
and α-ketoisocaproic acid (KIC) supplementation on signs and symptoms 
of exercise-induced muscle damage following a single bout of eccentrically 
biased resistance exercise. Six non-resistance trained male subjects performed 
an exercise protocol designed to induce muscle damage on two separate occa-
sions, performed on the dominant or non-dominant arm in a counter-balanced 
crossover design. Subjects were assigned to an HMB/KIC (3 g HMB and 0.3 
g  α-ketoisocaproic acid, daily) or placebo treatment for 14 d prior to exercise 
in the counter-balanced crossover design. One repetition maximum (1RM), 
plasma creatine kinase activity (CK), delayed onset muscle soreness (DOMS), 
limb girth, and range of motion (ROM) were determined pre-exercise, at 1h, 
24 h, 48 h, and 72 h post-exercise. DOMS and the percentage changes in 1RM, 
limb girth, and ROM all changed over the 72 h period (P < 0.05). HMB/KIC 
supplementation attenuated the CK response, the percentage decrement in 1RM, 
and the percentage increase in limb girth (P < 0.05). In addition, DOMS was 
reduced at 24 h post-exercise (P < 0.05) in the HMB/KIC treatment. In conclu-
sion, 14 d of HMB and KIC supplementation reduced signs and symptoms of 
exercise-induced muscle damage in non-resistance trained males following a 
single bout of eccentrically biased resistance exercise.
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β-hydroxy-β-methylbutyrate (HMB) is a metabolite of the branch chain amino acid 
leucine and its ketoacid α-ketoisocaproate (32). HMB has been used as a dietary 
supplement to increase carcass quality in livestock (31) and has recently gained 
popularity as a dietary supplement in humans, particularly among strength athletes 
(27, 28). Today, many commercial HMB supplements also contain a small amount 
of α-ketoisocaproic acid (KIC).
In man, the reported benefi ts of supplementation with dosages of between 
1.5 and 3.0 g/d HMB include reduced muscle protein degradation and consequent 
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increases in muscle mass and strength following resistance exercise training per-
formed for between 3 and 8 wk (9, 13, 20, 25); there is, however, some evidence 
that these benefi ts are not observed in well-trained subjects (16, 26). Creatine kinase 
activity in blood, which is a commonly used marker of sarcolemmal damage (4, 19, 
23), has also been shown to be reduced by HMB supplementation following resis-
tance training (9, 13, 20, 25) and prolonged running (14). Such protection against 
muscle damage has been attributed to the role of HMB in increasing cell membrane 
integrity via cholesterol synthesis and therefore reducing damage-induced prote-
olysis (21); in addition, it has been hypothesized, though not yet tested, that HMB 
might act as a structural component within the cell (20). 
Unaccustomed eccentric exercise has been widely reported to result in muscle 
damage with symptoms including reduced muscle function, elevated plasma creatine 
kinase activity, increased pain and swelling, and reduced range of motion (2, 4, 5, 
7, 8, 18). To date, only 1 study has identifi ed the effects of HMB supplementation 
on muscle damage resulting from a single bout of eccentric resistance exercise 
(24). Paddon-Jones et al. (24) found that 6 d HMB supplementation with 40 mg/kg 
body mass/d provided no attenuation of symptoms associated with exercise-induced 
muscle damage following 24 maximal eccentric contractions of the elbow fl exors; 
this fi nding refutes the proposed mechanisms of HMB enhancing cell membrane 
integrity. The authors concluded that a longer duration of supplementation could be 
necessary to determine whether HMB provides a protective effect against exercise-
induced muscle damage following a single bout of eccentric exercise.
Issues of product purity are paramount when investigating nutritional supple-
ments. It is well publicized that many sports supplements contain appreciable 
amounts of contaminants, which can make their use problematic for athletes who 
compete under World Anti-Doping Authority (WADA) rules. For example, it has 
been reported that consuming only 1 μg of nandrolone can result in a positive test 
for norandrosterone under International Olympic Committee (IOC) regulations (10). 
In addition, contamination with stimulants or anabolic steroids would confound 
any study investigating the effi cacy and ergogenic potential of nutritional supple-
ments. For these reasons, detailed analyses of the active ingredients and possible 
illegal contaminants (as identifi ed by WADA) were performed on the HMB/KIC 
supplement used in this study.
The aim of this study was to examine the effects of 14 d HMB and KIC 
supplementation on the signs and symptoms of exercise-induced muscle damage 
following a single bout of eccentrically biased resistance exercise.
Methods
Subjects
Eight male volunteers who had not performed any resistance training in the previ-
ous 12 months participated in this study. Two subjects were excluded from the data 
analysis due to one having elevated baseline plasma creatine kinase activity on 
the second trial and another being unable to complete the exercise protocol on the 
second occasion. Age, height, and body mass of the subjects (N = 6) were (mean ± 
standard deviation) 23 ± 4 y, 178.3 ± 5.8 cm, and 81.9 ± 18.4 kg, respectively. Prior 
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to participation, all subjects were informed of the procedures of the investigation 
and completed a pre-test health-screening questionnaire and provided written 
informed consent, according to ACSM guidelines (1). All experimental procedures 
were approved by the Kingston University Research Ethics Committee. Subjects 
were instructed to refrain from any form of resistance training, plyometrics, or other 
exercise that could potentially cause muscle damage for the 3 wk prior to and during 
testing. Adherence to these instructions was confi rmed to the test investigator on 
each visit to the laboratory.
HMB/KIC and Placebo Treatments
Subjects were assigned to the HMB/KIC and placebo treatments in a blind, counter-
balanced crossover design. The HMB/KIC treatment comprised a daily dose of 3 g 
β-hydroxy-β-methylbutyrate with 0.3 g α-ketoisocaproic acid (Maximuscle HMB 
1000, Maximuscle Ltd., Watford, U.K.); the placebo treatment comprised 3 g corn 
fl our daily. Each treatment was administered in the form of gelatine capsules taken 
daily in three equal doses after meals, for 14 d.
The purity of the HMB/KIC supplement was assessed by Fourier Transform 
Near Infrared (FTNIR) Spectroscopy using wavelengths scanning from 1000 to 2300 
nm. The possible presence of the major classes of stimulants and anabolic steroids 
that have been implicated as contaminants in nutritional supplements were assessed 
(Table 1). Contamination analyses were performed by an independent laboratory 
using mass spectrometry-based analytical methods developed specifi cally to detect 
contamination in nutritional supplements. These methods were accredited prior to 
sample analysis to ISO 17025, the required quality standard that underpins WADA 
testing procedures. The HMB/KIC capsules were homogenized and prepared for 
analyses using liquid-liquid and solid phase extraction techniques. Stimulants were 
assessed by liquid chromatography, with mass spectrometric detection to a level 
of 500 ng per gram of supplement. Steroids were assessed by gas chromatography 
with mass spectrometric detection to a level of 50 ng per gram of supplement. 
Muscle Damage Protocol
Following the 14 d supplementation, subjects performed an exercise protocol 
designed to induce muscle damage. This was performed on either the dominant 
or the non-dominant arm, to which subjects were assigned in a counter-balanced 
crossover design. The exercise protocol consisted of 3 sets of 10 repetitions of 
single arm biceps curls at 70% of a previously determined 1 repetition maximum 
(1RM) for the involved arm. The protocol was performed using an adjustable 
preacher curl bench, set at 140° (York 5, York Barbell UK Ltd, Daventry, U.K.). 
Repetitions were performed over the full range of motion with a normal concen-
tric contraction followed by a prolonged eccentric contraction lasting a period of 
10 s; this time was verbally communicated to the subject so a smooth and even 
contraction could be maintained. Assistance was provided if subjects were unable 
to complete the concentric phase of the repetition, however, there was no assistance 
during the eccentric phase, though verbal encouragement was given by the same 
test investigator. A rest period of 4 min was taken between sets.
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Dependent Variables
Measures of concentric 1RM, plasma creatine kinase activity (CK), muscle sore-
ness (DOMS), limb girth, and range of motion (ROM) were taken pre-exercise, 
and at 1 h, 24 h, 48 h, and 72 h post-exercise.
Concentric One Repetition Maximum (1RM). A preacher curl bench (as previ-
ously described) was used for the determination of 1RM. The defi nition and method 
of 1RM determination described by Kraemer and Fry (15) was adopted for this 
study. Reliability data from our laboratory for the determination of 1RM on two 
consecutive days using this method demonstrate a technical error of measurement 
(TEM) of 1.1% (i.e., 0.13 kg).
Plasma Creatine Kinase Activity (CK). A fi ngertip capillary blood sample 
collected in a 75 μl heparinized capillary tube (Hawksley & Sons, Ltd., Lancing, 
U.K.) was centrifuged for 3 min and the blood plasma drawn and frozen at –18 °C 
for subsequent analysis. CK was determined using enzymatic dry slide chemistry 
(VITROS DT60II, Ortho-Clinical Diagnostics, Amersham, U.K.). Data from our 
laboratory for the intra-assay reliability (N = 10) of this method to analyze low 
(87.5 IU/L), medium (636.1 IU/L), and high (1518.4 IU/L) concentrations provide 
coeffi cients of variation of 1.1%, 2.6%, and 1.3%, respectively.
Table 1 Stimulants and Steroids Analyzed in HMB and KIC
Stimulants Ephedrine
Pseudoephedrine
Norpseudoephedrine (cathine)
Phenylpropanolamine
Methylephedrine
Caffeine
Steroids  5(6)-androstene-3, 17-dione and/or 4-adrostene-3, 17-dione
 4-androstene-3beta, 17beta-diol
 5a-androst-1-ene-3beta, 17beta-diol
 5a-androstane-3beta, 17beta-diol
 5(6)-androstene-3beta, 17beta-diol
 5(10)-estrene-3, 17-dione (19-nor-5(10)-androstene-3, 17-dione) and/or
 4-estrene-3, 17-dione (19-nor-4 androstene-3, 17-dione) and/or
 5(6)-estrene-3, 17-dione (19-nor-5(6)-androstene-3,17-dione)
 4-estrene-3beta, 17beta-diol (19-nor-4 androstene-3beta, 17beta-diol)
 Nandrolone (19-nor-4-androstene-17beta-hydroxy-3-one)
 Testosterone
 Dehydroepiandrosterone (DHEA)
 1,4-androstene-3, 17-dione
 5a-androst-1-ene-3, 17-dione
 5a-androstane-3,17-dione
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Perceived Muscle Soreness Rating (DOMS). Perceived soreness was determined 
using the Talag scale (30), a subjective scale from 1 (no pain) to 7 (unbearably 
painful). Subjects stood with the shoulder of the exercised arm fl exed at 90° and 
the elbow fully extended; subjects were then asked to select a number from the 
scale that corresponded to the soreness felt.
Limb Girth. Limb girth of the upper arm was taken midway between acromion 
and olecranon processes using a fl exible anthropometric tape with the arm hung 
naturally at the side of the body. Reference points on the arm were marked with 
permanent ink to ensure consistency on subsequent days. Reliability data from our 
laboratory for the measurement of limb girth on two consecutive days using this 
method demonstrate a TEM of < 0.3% (i.e., < 0.1 cm).
Range of Motion (ROM). ROM of the elbow joint in fl exion and extension was 
assessed using a transparent, plastic goniometer (Baseline, Physiomed, Cheshire, 
U.K.); total ROM was determined using a method previously described (16). Refer-
ence points on the arm were again marked with permanent ink to ensure consistency 
on subsequent days. We have calculated a TEM of < 0.1% (i.e., < 1.1°) when using 
this procedure for the measurement of ROM on two consecutive days.
Statistical Analyses
Data are presented as means ± standard deviation; data for 1RM, limb girth, and 
ROM are expressed as percentage change from pre-exercise levels. All dependent 
variables were analyzed using a 2 factor (treatment, 2  time, 5) repeated measures 
analysis of variance (ANOVA). Mauchlyʼs sphericity test was used to check homo-
geneity of covariance. Violations of the assumption of sphericity were corrected 
using the Greenhouse-Geisser adjustment. Where a signifi cant interaction effect 
was found, Tukeyʼs post hoc tests were used to identify signifi cant differences. A 
signifi cance level of P < 0.05 was established prior to analyses.
Results
Eight subjects participated in this study, however, 1 subject was excluded due to 
elevated baseline CK (508 IU/L) in the second trial and another failed to complete 
the exercise protocol on the second occasion. Results are therefore presented for 
N = 6.
Figure 1 illustrates the percentage change in 1RM (lower panel) and CK 
(upper panel) for the two treatment conditions. There was a signifi cant change in 
1RM over the 72 h period (F = 31.122, P < 0.001), decreasing from 131.3 ± 10.8 
N in the placebo treatment and from 123.5 ± 25.5 N in the HMB/KIC treatment at 
pre-exercise, by approximately 20 N at 1 h post-exercise. There was a signifi cant 
difference between HMB/KIC and placebo treatments for the percentage change in 
1RM (F = 13.267, P < 0.05). Despite similar decreases at 1 h post-exercise in the 
2 treatments, the HMB/KIC treatment attenuated the decrement in 1RM over the 
72 h period. In addition, although not signifi cant, there was a slight increase in 1RM 
(~ 2.5 N) over pre-exercise levels after 48 h in the HMB/KIC treatment (Figure 
1, lower panel). There was a signifi cant difference in the CK response between 
treatments (F = 7.814, P < 0.05), which increased over the 48 h following exercise 
in the placebo treatment reaching a peak of 315.2 ± 194.6 IU/L; the HMB/KIC 
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treatment, however, showed very little increase in CK, rising from baseline levels of 
147.0 ± 33.8 IU/L to a peak of 154.5 ± 35.6 IU/L at 1 h post-exercise. No signifi cant 
change over time or treatment by time interaction were found for CK.
Results for DOMS and percentage change in limb girth are shown in Figure 
2 (upper and lower panels, respectively). DOMS signifi cantly increased following 
the exercise bout (F = 51.457, P < 0.001), reaching a peak at 24 h post-exercise in 
both treatments. There was a signifi cant treatment by time interaction (F = 2.895, 
P < 0.05), revealing that DOMS was lower at 24 h post-exercise in the HMB/KIC 
treatment, reaching 2.66 ± 0.51 in contrast to 3.33 ± 0.81 in the placebo treat-
ment (P < 0.05). There was an increase in limb girth following the exercise bout 
(F = 8.350, P < 0.01), which peaked at 24 h post-exercise in both treatments (increas-
ing by 1.3% and 1.2% in placebo and HMB/KIC treatments, respectively). There 
was a signifi cant difference in limb girth between treatments (F = 9.511, P < 0.05); 
Figure 2 (lower panel) illustrates that the percentage increase in limb girth was 
Figure 1 — 1RM (percentage change) and CK in HMB/KIC and placebo treatments; 
lower and upper panels, respectively.
*signifi cant difference between treatments (P < 0.05).
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attenuated in the HMB/KIC treatment over the 72 h post-exercise period. In addition, 
limb girth returned to pre-exercise levels at 72 h post-exercise in the HMB/KIC 
treatment though it remained slightly elevated in the placebo treatment.
There was a change in ROM over the 72 h period (F = 11.784, P < 0.001); 
similar trends were found in both treatment conditions, with decreases measured 
for up to 24 h post-exercise (Figure 3). Although not signifi cantly different, the 
percentage decrease in ROM was slightly lower in the HMB/KIC treatment (4.2° 
and 8.3° at 24 h post-exercise in the HMB/KIC and placebo treatments, respec-
tively). ROM increased from 24 h to 72 h post-exercise in both treatments though 
it did not reach baseline levels.
The results of the HMB and KIC analyses demonstrated both to be 98% pure, 
the remaining 2% being primarily moisture. No stimulants or anabolic steroids 
were found in the HMB/KIC supplement.
Figure 2 — Limb girth (percentage change) and DOMS in HMB/KIC and placebo treat-
ments; lower and upper panels, respectively.
$ signifi cant difference in DOMS between treatments at 24 h post-exercise, (P < 0.05).
*signifi cant difference between treatments (P < 0.05).
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Discussion
This is the fi rst study to show that HMB and KIC supplementation attenuates muscle 
damage in non-resistance trained males following a single bout of eccentrically 
biased resistance exercise. Supplementation for 14 d signifi cantly attenuated the 
increase in CK, DOMS, and limb girth, and the decrement in 1RM. The only vari-
able not affected by HMB and KIC supplementation was the percentage change 
in ROM. Our fi ndings are in contrast to those of the only other study reporting the 
effects of HMB supplementation on muscle damage consequent to a single bout 
of eccentric resistance exercise (24); however, we used a supplementation period 
of 14 d rather than 6 d as previously examined (24) and a supplement that also 
contained KIC.
The exercise protocol used in this study was effective in causing muscle 
damage as shown by the signifi cant changes in 1RM, DOMS, limb girth, and 
ROM over time. Although CK did not demonstrate a change over time, there was 
a difference between treatments, with increases in CK in the placebo treatment. 
These results support previous research identifying that a single bout of eccentric 
exercise causes signifi cant increases in signs and symptoms of muscle damage (5, 
7, 8, 12, 22, 23).
HMB and KIC supplementation had a signifi cant effect on the percentage 
decrement in muscle function following the eccentrically biased bout of resistance 
exercise. The results demonstrate that although there was a similar decrease in 1RM 
at 1 h post-exercise in both treatments, there was a greater decrement in strength in 
the placebo treatment over the study period. It is interesting to note that 1RM actually 
exceeded pre-exercise levels by 48 h post-exercise in the HMB/KIC trial, though 
this increase was not signifi cant. Although improved strength gains have been 
previously reported following HMB supplementation during a resistance training 
program (9, 13, 20, 25), Paddon-Jones et al. (24) found supplementation to have no 
effect on isometric or isokinetic muscle function over 10 d following a single bout 
of eccentric resistance exercise. In contrast, however, smaller decrements in muscle 
Figure 3 — ROM (percentage change) in HMB/KIC and placebo treatments.
06VanSomeren(413)   420 8/10/05, 8:40:49 AM
421 HMB/KIC and Muscle Damage
force have been reported with HMB supplementation, following downhill running 
(3). Any protective effect HMB and KIC might provide against exercise-induced 
muscle damage would be expected to result in diminished damage-induced prote-
olysis (21), thereby maintaining muscle tissue and attenuating losses in strength, 
as evidenced in this study.
HMB and KIC supplementation signifi cantly attenuated the CK response, 
indicating that muscle damage was reduced following the exercise protocol, perhaps 
via enhanced cell membrane integrity with a consequent reduction in CK effl ux 
from the cell. Although no direct evidence exists as to exact mechanisms, HMB 
has been hypothesized to act as a precursor for cholesterol synthesis via its metabo-
lism to β-hydroxy-β-methylglutaryl CoA (HMG-CoA), thus providing a carbon 
source for cholesterol synthesis (21). An increase in intracellular cholesterol could 
enhance cell membrane integrity and therefore reduce muscle damage following 
unaccustomed or intense exercise (21). Another hypothesis is that HMB serves as 
a structural component within the cell membrane (20). The mechanisms by which 
KIC might reduce muscle damage are again unclear; however, given that KIC is 
a precursor to HMB, it is likely that it acts on the muscle cell in the same way. 
Although the results of the present study do not directly confi rm these hypotheses, 
it is clear that HMB and KIC supplementation did provide protection and attenuated 
muscle damage following a single bout of eccentrically biased resistance exercise. 
Our fi nding of reduced CK concurs with a number of previous studies reporting 
HMB supplementation to reduce CK following resistance training (9, 13, 20, 25) 
and prolonged running (14). The only other study found in the literature to have 
reported the effects of HMB supplementation on muscle damage caused by a single 
bout of eccentric resistance exercise (24) did not, however, measure CK.
Large inter-subject variation in CK in response to exercise has previously 
been reported as a limitation in its use in establishing the extent of muscle damage 
(6, 11, 29). It is therefore interesting to note that in the current study, although 
there is considerable variation between subjects in the placebo trial (Figure 1), the 
HMB/KIC trial showed very little inter-subject variation, indicating that HMB and 
KIC provided a protective effect in all subjects.
Muscle soreness was signifi cantly lower in the HMB/KIC treatment at 24 h 
post-exercise. This is in contrast to the fi ndings of Paddon-Jones et al. (24) who 
found that muscle soreness assessed using a 10 point visual analog scale was 
not reduced with 6 d HMB supplementation following a single bout of eccentric 
exercise. HMB supplementation for 28 d has, however, been previously shown to 
reduce muscle soreness following 30 min downhill running (3). Any mechanism by 
which HMB and KIC could affect soreness has not yet been identifi ed (27), though 
it is likely to be a consequence of the reduced myofi brillar damage due to enhanced 
cell membrane integrity manifested by HMB and KIC supplementation.
Limb girth was measured in this study as an indirect marker of swelling and 
edema. HMB and KIC supplementation signifi cantly attenuated the increase in 
limb girth following exercise. Since CK, 1RM, and DOMS all indicated reduced 
muscle damage with HMB/KIC supplementation, it is concordant that swelling and 
edema were reduced. Again, our fi nding is in contrast to that of Paddon-Jones et 
al. (24) who found HMB supplementation to have no effect on post-exercise limb 
girth. This difference might be attributable to the longer supplementation period 
used in our study.
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Independent testing of the active ingredients in the HMB/KIC supplement 
demonstrated 98% purity. The analyses of stimulants and steroids showed that 
consumption of the HMB and KIC as performed in this study would not infringe 
IOC rules. These analyses also demonstrate that the effects of the HMB/KIC supple-
ment were not due to stimulant or steroid contaminants.
In conclusion, and in contrast to previous literature examining shorter dura-
tion supplementation (24), we found that 14 d supplementation with HMB and 
KIC reduced signs and symptoms associated with exercise-induced muscle damage 
in non-resistance trained male subjects. This is the fi rst study to demonstrate that 
HMB/KIC supplementation is effective in the management and reduction of muscle 
damage following a single bout of eccentrically biased resistance exercise. Further 
research is required to confi rm these fi ndings and to elucidate the mechanisms 
by which HMB/KIC supplementation could provide protection against exercise-
induced muscle damage. In addition, investigation of the protective effects of HMB 
and KIC supplementation for acute exercise in resistance-trained populations is 
warranted.
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